These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6520229)

  • 61. Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.
    Goldstein D; Sielaff KM; Storer BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC
    J Natl Cancer Inst; 1989 Jul; 81(14):1061-8. PubMed ID: 2472488
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction of 2'-5' oligoadenylate synthetase during interferon treatment of chronic myelogenous leukemia.
    Moritz T; Weissmann B; Grünewald B; Hust H; Kummer G; Niederle N
    Mol Biother; 1992 Jun; 4(2):97-102. PubMed ID: 1381190
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Postimmunization activity of oligoadenylate synthetase in peripheral blood lymphocytes from healthy individuals.
    Bonnevie-Nielsen V; Heron I; Kristensen T; Michelsen B; Lernmark A
    J Clin Lab Immunol; 1989 Apr; 28(4):155-60. PubMed ID: 2483411
    [TBL] [Abstract][Full Text] [Related]  

  • 64. (2'-5')oligo(A) synthetase as a monitor of interferon action in juvenile laryngeal papillomatosis.
    Lodemann E; Kornhuber B; Gerein V; von Il'berg C
    J Interferon Res; 1984; 4(2):283-90. PubMed ID: 6747349
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Analysis of oligo-2',5'-adenylate by fast polynucleotide liquid chromatography (HPLC)].
    Yashiki T; Fujii N; Oguma K; Fukatsu R; Fujii M; Takahata N
    Rinsho Byori; 1988 Mar; 36(3):339-45. PubMed ID: 3404725
    [No Abstract]   [Full Text] [Related]  

  • 66. Extravascular administration of interferon alfa-N3 increases serum exposure and 2-5(A) synthetase activity.
    Sturgill MG; Rashidbaigi A; Liao MJ; Zhao XX; Hua J; Trout R; Knill JR; Grasing KW
    J Clin Pharmacol; 2000 Jun; 40(6):606-15. PubMed ID: 10868311
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C.
    Jakschies D; Zachoval R; Müller R; Manns M; Nolte KU; Hochkeppel HK; Horisberger MA; Deicher H; Von Wussow P
    Hepatology; 1994 Apr; 19(4):857-65. PubMed ID: 8138257
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Porcine conceptus proteins: antiviral activity and effect on 2',5'-oligoadenylate synthetase.
    Short EC; Geisert RD; Groothuis PG; Blair RM; Schmitt RA; Fulton RW
    Biol Reprod; 1992 Mar; 46(3):464-9. PubMed ID: 1319754
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines.
    Penn LJ; Williams BR
    J Virol; 1984 Mar; 49(3):748-53. PubMed ID: 6199512
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Interferon (IFN)-alpha, beta, gamma].
    Uno K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():89-92. PubMed ID: 16149460
    [No Abstract]   [Full Text] [Related]  

  • 72. Analysis of 2'5' oligo (A) synthetase in patients with advanced thyroid carcinoma.
    Vainas I; Dimitriadis K; Stergiou I; Tsirintanis I; Galaktidou G; Kortsaris AH
    Int J Biol Markers; 1995; 10(2):115-6. PubMed ID: 7561236
    [No Abstract]   [Full Text] [Related]  

  • 73. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
    Andreone P; Cursaro C; Gramenzi A; Buzzi A; Miniero R; Sprovieri G; Gasbarrini G
    J Hepatol; 1994 Dec; 21(6):984-8. PubMed ID: 7699263
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C.
    Giannelli G; Antonelli G; Fera G; Dianzani F; Schiraldi O
    J Interferon Res; 1993 Feb; 13(1):57-60. PubMed ID: 8454912
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Serum adenosine deaminase and angiotensin converting enzyme activity in patients with endogenous uveitis].
    Fukami R; Ohba S; Ishida K; Nakamura S; Konno M; Ohno S
    Nippon Ganka Gakkai Zasshi; 1994 Mar; 98(3):287-92. PubMed ID: 8154388
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Interferon-inducible genes 2', 5'-ollgoadenylate synthetase-like and tetratricopeptide repeats 2 are correlated with clinical features of patients with systemic lupus erythematosus].
    Zhao ZY; Yang NP; Huang XY; Min L; Liu XX; Zhang J; Ye Y; Shi LJ; Zhong X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):247-51. PubMed ID: 20506645
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [2-5 Oligoadenylate synthetase].
    Koura T; Kato Y; Unoura M
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():202-5. PubMed ID: 8753217
    [No Abstract]   [Full Text] [Related]  

  • 78. [Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
    Daito K; Suou T; Kawasaki H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):981-5. PubMed ID: 7563914
    [No Abstract]   [Full Text] [Related]  

  • 79. Combined therapy with cisplatin and interferon alpha-2b (INTRON-A) in patients with penile carcinoma. Analysis of 2'5' oligo (A) synthetase and circulating interferon.
    Mouratidou D; Kortsaris AH; Andreadis C; Galaktidou G; Vakalikos I
    Int J Biol Markers; 1996; 11(1):55-7. PubMed ID: 8740645
    [No Abstract]   [Full Text] [Related]  

  • 80. [Serum interferon level and (2'-5')-oligo(A) synthetase activity in malignant melanoma].
    Lodemann E; Lang MH; Oelmann R; Holzmann H
    Z Hautkr; 1990 Apr; 65(4):404-6. PubMed ID: 1695048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.